Crinetics held a conference call and live audio webcast discussing the results of the CRN04894 single ascending dose cohorts from the first-in-human Phase 1 clinical study.
News & Events
Crinetics Reviews CRN04894 Single-Ascending Dose Results
Transforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine care.